Lyumjev – A New Insulin Lispro for Diabetes

Date:  October 19, 2020 Issue #:  1609 Summary:  The FDA has approved insulin lispro-aabc (Lyumjev – Lilly), a faster-acting formulation of insulin lispro (Humalog), for treatment of type 1 and type 2 diabetes in adults. Fiasp, a faster-acting formulation of insulin aspart (Novolog), was approved in 2017.